Prof. Dr. Mikako Ogawa: Advancing Radiochemistry for Molecular Imaging and Targeted Therapies
From Molecular Design to Clinical Application
Prof. Dr. Mikako Ogawa is a leading expert in radiochemistry and molecular imaging. As Professor at Hokkaido University, she conducts pioneering research on the development of novel compounds for imaging and targeted therapy, bridging chemistry, biology, and clinical application.
Her work focuses on designing functional molecules that enable visualization and modulation of biological processes in vivo. By combining chemical innovation with nuclear and optical technologies, she contributes to advancing theranostics as a truly interdisciplinary field.
Research Excellence and Scientific Innovation
Prof. Ogawa’s research spans molecular targeted imaging, radiopharmaceutical development, and photoimmunotherapy. Her work includes the development of innovative compounds activated by light or radiation, enabling highly selective imaging and therapeutic strategies.
With more than 150 scientific publications and a strong citation record, she is widely recognized for her contributions to chemical biology and cancer research. Her studies on near-infrared photoimmunotherapy and targeted molecular imaging have opened new avenues for precision oncology.
Her international research experience, including work at the National Institutes of Health (NIH), has further strengthened her global scientific perspective.
Leadership and Scientific Engagement
Beyond her research, Prof. Ogawa plays an active role in the scientific community through editorial work, advisory functions, and leadership positions in academic societies. She contributes to shaping research strategies in molecular imaging, radiochemistry, and drug development at both national and international levels.
Her work reflects a strong commitment to interdisciplinary collaboration, connecting chemistry, physics, and medicine to drive innovation in theranostics.
Shaping the Scientific Profile of TWC2027
As Co-President of the 9th Theranostics World Congress (TWC2027), Prof. Ogawa brings deep expertise in radiochemistry and molecular innovation. Her perspective strengthens the scientific foundation of the congress, particularly in areas such as compound development, imaging technologies, and next-generation therapeutic approaches.
Through her leadership, TWC2027 will further highlight the critical role of chemistry-driven innovation in advancing Radiomolecular Precision Medicine.